What does the new administration mean for Wall Street? Jim Cramer's first reaction to the election is live on TheStreet's Facebook page tomorrow morning at 8 a.m. EST. He joins our team of reporters along with experts and analysts tracking the markets with us.
As millions of Americans headed to the polls Tuesday, the markets ticked up for a second straight day, reversing nine straight days of declines. The positive sentiment comes as Hillary Clinton remains the clear favorite over her Republican foe Donald Trump.
Sure, the election was the focal point for investors, pundits and the rest of Wall Street. But there were other things going on today as well. TheStreet and its properties today followed a number of intriguing stories -- some election-related, some not.
Did you hear Valeant (VRX) got hammered today after a relative shit-show of a third quarter and the subsequent conference call? Or that CVS Corp. (CVS) lowered its guidance and brought the whole pharmacy sector down with it? No? Well, here is your chance to catch up, plus a little election coverage for posterity.
Here are the highlights:
Finra Arbitrators Not Keen on Disclosing Conflicts in Private Court Proceedings
If you're an investor with a beef about your broker, you're stuck using a private court run by the securities industry instead of a normal court of law. Full story
Gilead Sciences' Next Challenge to Incyte's Myelofibrosis Drug Dominance
Gilead Sciences (GILD) is nearing the completion of two phase III studies of the Jak inhibitor momelotinib in myelofibrosis, a disease affecting bone marrow. Full story
Is Trump a Bad Omen or Simply a Black Swan for TV Political Advertising?
'You can't get blood from a Trump,' says Gray Television CEO Hilton Howell, Jr., of the GOP candidate's impact on political spending. Full story
Tweet of the Day:
Priceline's Stellar M&A Track Record Intact Despite OpenTable Writedown
Priceline (PCLN) takes a writedown of $941 million for the OpenTable division a little over two years after acquiring the restaurant booking company. Full story
Chart of the Day: Can CSX Stay On Track?
CSX (CSX) has rallied nicely this year, bottoming in January and February, and buyers using weakness below $23 to get long. CSX has chugged higher making a new high for the move up yesterday. Full story
Kindred Calls It Quits on Skilled Nursing Business
The healthcare services company throws in the towel on its worst performing unit. Sale talks are underway with Ventas. Full story
3 Companies That Growth-Starved Telcos Like Frontier and Verizon (VZ) Could Target
U.S. telcos have been turning to M&A to offset revenue pressures and protect their rich dividends. That leaves conditions ripe for further dealmaking. Full story
Video of the Day: Buy China, Russia Heading Into 2017 But Not Mexico
Emerging market stocks are on a tear in 2016 and that momentum could extend into 2017, especially in countries like China and Russia. Full story